Loading people...
Jacob Haddad is the CEO and Co-Founder of Accurx and an active angel investor based in London, United Kingdom. He established the healthcare communication platform in 2016 to address critical infrastructure and workflow challenges within the medical sector. Under his leadership, Accurx has scaled its software to serve over 98% of general practitioner practices across the National Health Service (NHS) and facilitated the booking system for more than 30 million COVID-19 vaccinations. The enterprise has secured over £35 million in total venture funding, highlighted by a £27.5 million Series B round led by Atomico alongside LocalGlobe. Prior to founding Accurx, he worked in healthcare strategy consulting and earned a Mechanical Engineering degree from the University of Bristol. Haddad currently focuses on expanding B2B SaaS healthtech solutions while supporting early-stage founders through targeted angel investments.
Jacob Haddad stands out as a prominent figure in the UK's healthcare technology landscape, primarily known as the visionary co-founder and CEO of AccuRx. While his primary focus has been on building and scaling AccuRx into a critical platform for patient-clinician communication, his profound entrepreneurial success and deep domain expertise position him as a highly influential voice and potential strategic investor within the health tech ecosystem.
Before embarking on his entrepreneurial journey, Jacob Haddad trained and worked as a doctor, gaining firsthand experience with the challenges and inefficiencies within healthcare systems. This invaluable clinical insight directly fueled the creation of AccuRx in 2016. Under his leadership, AccuRx has revolutionized how healthcare providers communicate with patients, offering solutions that streamline appointments, manage prescriptions, and deliver vital information efficiently. The platform's rapid adoption and significant impact, particularly during the COVID-19 pandemic, underscore Jacob's ability to identify critical needs and develop scalable, impactful technological solutions. His journey from clinician to successful tech CEO provides him with a unique perspective on both the clinical realities and the technological possibilities within healthcare.
Given his extensive background, Jacob Haddad's potential investment focus areas would likely center on innovations that mirror or complement AccuRx's mission. He would be particularly interested in early-stage companies developing solutions in digital health, artificial intelligence (AI) applied to healthcare, patient engagement platforms, and software-as-a-service (SaaS) tools designed to improve operational efficiency for healthcare providers. His operational experience in navigating regulatory landscapes, building product-market fit, and scaling a tech company within the complex healthcare sector would make him an invaluable advisor to portfolio companies. He would likely seek out founders with a clear vision, deep understanding of healthcare challenges, and strong execution capability.
While Jacob Haddad's public profile is predominantly as a founder and CEO, his operational acumen and strategic insights are highly sought after. As an investor or advisor, he would bring more than just capital; he would offer hands-on guidance on product development, market strategy, team building, and navigating the nuances of the health tech industry. His experience in securing significant funding rounds for AccuRx also provides him with a keen understanding of investor expectations and growth trajectories.
At present, Jacob Haddad's primary entrepreneurial focus remains firmly on AccuRx, and public records of his personal angel investments or venture capital activities are not widely publicized. However, his track record with AccuRx itself serves as a testament to his ability to identify and nurture high-potential ventures from inception to market leadership. Any future investments would undoubtedly benefit from his proven ability to spot transformative technologies and guide them toward success.
Jacob Haddad represents a new generation of entrepreneurs who are not only building successful companies but are also poised to shape the future investment landscape. His deep understanding of healthcare, combined with his entrepreneurial drive, positions him as a significant potential force in identifying and backing the next wave of health tech innovators, driving forward solutions that genuinely improve patient care and system efficiency.
While primarily focused on AccuRx, Jacob Haddad, drawing from his expertise, would likely invest in early-stage digital health, AI in healthcare, patient engagement platforms, and SaaS tools for healthcare providers. His focus would be on transformative health tech innovations.
Jacob Haddad works as the CEO and co-founder of AccuRx, a prominent healthcare technology company headquartered in the United Kingdom.